Conclusion
In conclusion, PH in pregnancy carries a high mortality. The
management of these patients in the ICU is challenging with
unique pregnancy-related physiologic changes and concern
for fetal safety. During the past decade, new advanced
therapies for pulmonary hypertension and cardiopulmonary
support devices have emerged. Their application in preg-
nant women is based on limited evidence and data
extrapolated from the nonpregnant population. Improved
maternal and fetal survival in recent years is attributable
to improved understanding of pulmonary hypertension,
advanced therapies, and adoption of a multidisciplinary
treatment approach.